Vascepa Is Safe and Should Be Approved by End of Year, Amarin CEO Says
https://youtube.com/watch?v=xQ_G4xrysT8
Aug.28 — John Thero, Amarin Corp. chief executive officer, discusses the company’s plans for its cardiovascular drug Vascepa. He speaks with Bloomberg’s David Westin on “Balance of Power.”
